Andere Sprachen Spyre Therapeutics, Inc.

Aktien

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 17.06.2024			% 5 Tage	% 1. Jan.
25.43 ^USD	-19.30%		-30.31%	+18.17%

13:30	Spyre Therapeutics, Inc. kündigt erste Teilnehmerdosis in Phase 1-Studie von SPY001 an	CI
15.05.	Spyre Therapeutics, Inc. kündigt Änderungen im Vorstand an	CI

Spyre Therapeutics, Inc. Announces First Participants Dose in Phase 1 Trial of SPY001	13:30
Spyre Therapeutics Announces Grants of Inducement Awards	03.06.
Spyre Therapeutics to Participate in the Jefferies Global Healthcare Conference	29.05.
Spyre Therapeutics Appoints Accomplished Biopharma Leader Dr. Sandra Milligan to its Board of Directors	16.05.
Spyre Therapeutics, Inc. Announces Board Changes	15.05.
Spyre Therapeutics: Q1 Earnings Snapshot	09.05.
Spyre Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
Spyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update	09.05.
Spyre Therapeutics Announces Grants of Inducement Awards	06.05.
Spyre Therapeutics Announces Grants of Inducement Awards	03.05.
Sector Update: Health Care Stocks Steady Pre-Bell Friday	19.04.
Spyre Therapeutics Files Mixed-Securities Shelf Registration for About 33.4 Million Shares	19.04.
Spyre Therapeutics Announces Grants of Inducement Awards	01.04.
Spyre Therapeutics, Inc. announced that it expects to receive $180.005 million in funding	18.03.
North American Morning Briefing : Powell Still in -2-	07.03.
Spyre Therapeutics Announces Grants of Inducement Awards	04.03.
North American Morning Briefing : Stock Futures -2-	04.03.
Spyre Therapeutics Announces Grants of Inducement Awards	01.03.
Spyre Therapeutics: Q4 Earnings Snapshot	29.02.
Spyre Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29.02.

Keine Ergebnisse zu dieser Suche